Overshadowed by MannKind’s 75%-plus jump in shares, another biotech by the name of Myriad Genetics Corp. also caused a stir on Wall Street Wednesday after it reported a raise in 2014 reimbursement from government-run health care programs.
Myriad MYGN +1.86% shares jumped nearly 14% in recent action to $39.97 on the news, released in a Securities and Exchange Commission filing late Tuesday.
Help employers find you! Check out all the jobs and post your resume.
